Business
Aptus Pharma Ltd. Press Release May 13 2026
The Exchange has received the disclosure under Regulation 29(1) / 2(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Tejash Hathi
About this update from Aptus Pharma Ltd.
The Exchange has received the disclosure under Regulation 29(1) / 2(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Tejash Hathi View Attachment